FeesSafety
Pluang+

Conavi Medical extends credit facilities with Japan Lifeline to 2032, boosting financial flexibility for U.S. OCTIV™ commercialization.

Company Fundamentals
18 Nov 2026, 14:15 WIB
GlobeNewsWire
View Source
Bullish
Conavi Medical extends credit facilities with Japan Lifeline to 2032, boosting financial flexibility for U.S. OCTIV™ commercialization.

Conavi Medical Corp. has extended its senior secured credit facilities with Japan Lifeline Co., Ltd. by five years, moving the maturity date from April 2027 to April 2032. This extension supports Conavi's commercial development plans following FDA clearance and initial U.S. clinical use of its OCTIV™ hybrid imaging system for cardiovascular procedures. Although the interest rate will rise from 6.5% to 10%, Conavi is not required to make interest payments until maturity, enhancing financial flexibility. The company aims to expand hospital placements, increase physician adoption, and generate more clinical evidence to support its imaging technology.

Conavi Medical's credit facility extension is presented here alongside Pluang's health-sector market snapshot as of Nov 18, 2026 19:21 WIB: out of 150 priced US health stocks, 55 rose and 86 fell. Among notable movers, SLS traded at USD 18.61 with a slight 1-day decline of -2.82% and balanced buy/sell activity, while LQDA dropped 2.71% to USD 55.19 with exclusively sell orders, contrasting with RXRX which gained 2.57% to USD 2.79 despite predominantly sell orders. This range of price movements and order activities illustrates diverse investor sentiment within the sector on Pluang.

More News

Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft's stock fell 2.27% to $506.24 following global outages affecting its Copilot, Teams, and Outlook services. The outages, attributed to server issues rather than cyberattacks, raised concerns amid broader software sector weakness. Oppenheimer...

Market News
Bearish
57 minutes ago
Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target Corporation reported earnings per share of $2.65, beating estimates of $2.08, and revenue of $27.1 billion, surpassing the $26.5 billion forecast. The company achieved its strongest quarterly sales growth in about five years, with net sales up...

Company Fundamentals
Bullish
1 hour ago
Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics announced its participation in the Piper Sandler 38th Annual Healthcare Conference from December 1-3, 2026, in New York City. CEO Daniel Barber will present on December 2 at 10:30 am ET, with one-on-one investor meetings schedu...

Market News
Neutral
1 hour ago
Raymond James upgrades Charles Schwab to Strong Buy as client assets hit $13.27T in Oct 2026

Raymond James upgrades Charles Schwab to Strong Buy as client assets hit $13.27T in Oct 2026

Raymond James upgraded Charles Schwab to Strong Buy following strong growth in October 2026. Client assets rose 12% year over year to $13.27 trillion, with core net new assets surging 50% to $66.5 billion, a record for the month. Schwab also opened 4...

Analyst Insights
Bullish
2 hours ago
SDVerse named CES Innovation Awards 2027 Honoree for AI-powered automotive software marketplace.

SDVerse named CES Innovation Awards 2027 Honoree for AI-powered automotive software marketplace.

SDVerse, a B2B automotive software marketplace founded by General Motors, Magna, and Wipro, was honored with a CES Innovation Award 2027 in the Enterprise Tech category. The platform uses AI and standardized technical data to help automakers and supp...

Others
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App